Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Guardado en:

Detalles Bibliográficos
Autores principales:	Yuka Shibata, Hideki Nakajima, Kimiko Nakajima, Satoshi Serada, Minoru Fujimoto, Tetsuji Naka, Shigetoshi Sano
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/c090de91f86641428a9bec3566a15ee0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:c090de91f86641428a9bec3566a15ee0
record_format	dspace
spelling	oai:doaj.org-article:c090de91f86641428a9bec3566a15ee02021-11-10T05:50:45ZLeucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis2574-459310.1002/cia2.12174https://doaj.org/article/c090de91f86641428a9bec3566a15ee02021-08-01T00:00:00Zhttps://doi.org/10.1002/cia2.12174https://doaj.org/toc/2574-4593Yuka ShibataHideki NakajimaKimiko NakajimaSatoshi SeradaMinoru FujimotoTetsuji NakaShigetoshi SanoWileyarticleDermatologyRL1-803Immunologic diseases. AllergyRC581-607ENJournal of Cutaneous Immunology and Allergy, Vol 4, Iss 4, Pp 86-88 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
spellingShingle	Dermatology RL1-803 Immunologic diseases. Allergy RC581-607 Yuka Shibata Hideki Nakajima Kimiko Nakajima Satoshi Serada Minoru Fujimoto Tetsuji Naka Shigetoshi Sano Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
format	article
author	Yuka Shibata Hideki Nakajima Kimiko Nakajima Satoshi Serada Minoru Fujimoto Tetsuji Naka Shigetoshi Sano
author_facet	Yuka Shibata Hideki Nakajima Kimiko Nakajima Satoshi Serada Minoru Fujimoto Tetsuji Naka Shigetoshi Sano
author_sort	Yuka Shibata
title	Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_short	Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_full	Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_fullStr	Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_full_unstemmed	Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
title_sort	leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/c090de91f86641428a9bec3566a15ee0
work_keys_str_mv	AT yukashibata leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT hidekinakajima leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT kimikonakajima leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT satoshiserada leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT minorufujimoto leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT tetsujinaka leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis AT shigetoshisano leucinericha2glycoproteinisapredictivemarkeroftherapeuticefficacyofthebiologicsinpsoriaticarthritis
_version_	1718440594176475136

Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis

Ejemplares similares